Internal Medicine, Endocrinology, Diabetes, & Metabolism · Humacao, PR
NPI
1073517355
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
18 J. Franceschi St., Urb. Pereyo
Humacao, PR, 00791
Phone (787) 852-5313
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,677
56 services
Medicare patients, 2024
27
Average age 74
Drug cost, 2024
$2.5M
12,672 prescriptions
Company payments, 2025
$958
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Myriam Z Allende-Vigo was code 99214 (office e&m - established), 39 times for 27 patients. In total Myriam Z Allende-Vigo billed 56 services in 6 codes, and Medicare paid $3,677.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 39 | 27 | $72.52 | $2,828 |
By year: 2022 $7,590 for 137 services; 2023 $8,234 for 131 services; 2024 $3,677 for 56 services.
Medicare prescription drug claims, 2024
In 2024, the drug Myriam Z Allende-Vigo prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,239 prescriptions and refills. In total Myriam Z Allende-Vigo wrote 12,672 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,239 | 1,788 | 219 | $80K |
| Atorvastatin Calcium Generic | 571 | 886 | 152 | $4,933 |
| Gabapentin Generic | 553 | 641 | 100 | $3,704 |
| Rosuvastatin Calcium Generic | 505 | 698 | 114 | $4,379 |
| Jardiance Empagliflozin | 474 | 532 | 76 | $326K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 432 | 476 | 72 | $35K |
| Ozempic Semaglutide | 429 | 442 | 65 | $422K |
| Losartan Potassium Generic | 382 | 596 | 106 | $3,464 |
| Trulicity Dulaglutide | 341 | 355 | 58 | $353K |
| Metformin Hcl Generic | 302 | 407 | 73 | $2,016 |
| Amlodipine Besylate Generic | 281 | 417 | 78 | $1,444 |
| Synjardy Empagliflozin/Metformin Hcl | 262 | 283 | 43 | $172K |
| Ezetimibe Generic | 256 | 342 | 56 | $3,384 |
| Levothyroxine Sodium Generic | 251 | 413 | 62 | $2,746 |
| Glimepiride Generic | 215 | 272 | 43 | $1,990 |
Brand drugs: 4,988 claims; generic drugs: 7,007 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Myriam Z Allende-Vigo $958 ($958 in general payments such as food, travel and fees) from 9 companies. The largest payer was Novo Nordisk Inc with $389.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 6 | $389 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $138 |
| Corcept Therapeutics CORT | 1 | $125 |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 1 | $84.39 |
| Lilly USA, LLC LLY | 1 | $69.5 |
| Amgen Inc. AMGN | 1 | $66.84 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $49.41 |
| Abbott Laboratories ABT | 2 | $35.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.